GlassScriptPhysician profile
Matthew D Martin
NPI 1912169095
$3,727.08
in general payments reported to CMS, 2019-2025
10 companies · $1,697 in 2025
The $1,697 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.77 · 2020: $194 · 2021: $475 · 2022: $231 · 2023: $521 · 2024: $543 · 2025: $1,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,428 · Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,427.85 |
| Food and Beverage | $1,334.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,463.73 | 2020-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Mentor Worldwide LLC | $1,106.62 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $585.14 | 2020-2022 | |
| Tela Bio, INC. | $187.81 | 2021-2024 | Ovitex 2s |
| Ethicon US, LLC | $135.57 | 2023 | Stratafix |
| Abbvie INC. | $128.27 | 2023-2025 | |
| Organogenesis INC. | $52.31 | 2023 | Puraply |
| W. L. Gore & Associates, INC. | $27.24 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Stryker Corporation | $21.33 | 2024 | Dart-Fire, Conextions Tr Tendon Repair System-Implant Mechanism |
| Medwest Associates | $19.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.